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Background
The Authors report a case of chronic cutaneous lesions
in a patient affected by prolidase deficiency, a rare dis-
order inherited through an autosomal recessive gene
(50 cases reported).
The enzyme prolidase is widely distributed throughout
the body and it is important in the recycling of proline
and hydroxyproline. Among the clinical presentations,
the most striking manifestation is the skin fragility with
leg ulceration (see Table 1).
The deficiency of the enzyme prolidase is responsible
for massive loss of proline in the urine which is esti-
mated to be as high as 3 g/die. The diagnosis is ascer-
tained by iminopeptiduria greater than 5 mmol/24h. A
characteristic feature is absolute resistance to all forms
of treatment including rejection of skin grafts.
Materials and methods
A 42 year-old woman affected by Prolidase Deficiency
was observed because of the recurrence of leg ulcers
(Figure 1). All clinical findings and laboratory data (imi-
nopeptiduria > 6 mmol/die) lead to a diagnosis. Admin-
istration of corticosteroids and of ointments were
performed with no results. In 1998 an autologous skin
transplant with the rejection of a skin graft. In 2007
administration of high dose corticosteroids with a partial
regression of symptomatology. In October 2008 clinical
feature suggested to cover all the lesion with hologous
skin graft which was then partially rejected.
In January 2009 and all lesions were covered and dur-
ing follow-up the use of autologous PLT-gel for 10
weeks was proposed. From the third application clinical
data showed good results and after the tenth application
all the lesions were treated with advanced devices. No
signs of infection were present. The patient is now
going into complete remission of skin lesions.
Discussion
Use of platelet gel is commonly accepted for the treat-
ment of leg ulcers because it is rich in growth factors.
Their presence could be a key to block the onset of a
flogistic reaction to proline and hydroxyproline account
in derma. All clinical investigations shows that after the
PLT gel application there is not a rejection to homo-
logous skin implants but an improvement in symptoma-
tology and inability.
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Table 1 Clinical signs of prolidase deficiency
Mental
retardation
Narrowed eyes Recurrent
infections
Splenomegaly
Saddle nose Hypoplasia of the
jaws
Talipes equines Protuberant
abdomen
Photosensitivity Dry crusted lesions Osteoporosis
Purpura Dry fissured
erythematous
Palms and soles
Corneal opacity
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Figure 1 PD skin lesions before and after combined treatmnet
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